The New England Region ATS will hold its annual event at LeMeridien-Cambridge-MIT. Our topic this year is “Today & Tomorrow – The Worlds of Healthcare and Data Security.”
Our guest panelists include Dr. Kevin Tabb, M.D., CEO of Beth Israel Deaconess Medical Center, and Mr. Omer Schneider, co-founder of CyberX. Our panel moderator will be Mr. Aron Ain, CEO of Kronos.
Please contact the ATS office for more information: 617-964-0048 or email@example.com.
* Registration closes on October 26th
20 Sidney St
Cambridge, MA 02139
$1,000.00 Benefactor (2 tickets plus listing in program booklet)
$3,000.00 Associate Sponsor (5 tickets, listing in program book and event posters, pre-reception with speakers)
$6,000.00 Sponsor (10 tickets, listing in program book and event posters, pre-reception with speakers)
$15,000.00 Platinum Sponsor (25 tickets, exclusive signage, listing in program book and event posters, private reception with speakers)
CJP provides the above links concerning third-party events for your convenience only. CJP has no control over the content of the linked-to websites or events they describe, and accepts no responsibility for the websites, including any advertising or products or services on or available from such sites, or for any loss or damage that may arise from your attending, or registering to attend, the described events. If you decide to access any of the third-party websites linked to below, you do so entirely at your own risk and subject to the terms and conditions of use for such websites and event attendance. CJP is not responsible or liable to you or any third party for the content or accuracy of any materials provided by any third parties. All statements and/or opinions expressed in the linked-to materials or at the described events, and all commentary, articles and other content provided at the third-party websites or at the events, are solely the opinions and the responsibility of the persons or entities operating the linked-to websites and events. The inclusion of any link on this website does not imply that CJP endorses the described event, or the linked-to website or its operator.